Related Party Transactions - Additional Information (Details) - Reignite Agreement $ in Thousands |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|---|
|
Mar. 31, 2024
USD ($)
Product
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
|
| Related Party Transaction [Line Items] | |||||
| Research and development expenses | $ 300 | $ 400 | $ 700 | $ 500 | |
| Option exercise fee | 0 | 0 | |||
| Option exercise fees per selected capsid | $ 1,000 | ||||
| Unpaid research and development expense | $ 100 | $ 100 | |||
| Maximum | |||||
| Related Party Transaction [Line Items] | |||||
| Related party expenses | 1,500 | ||||
| Equipment costs | $ 60 | ||||
| Number of capsids | Product | 3 | ||||
| Option exercise fee | $ 3,000 | ||||
| X | ||||||||||
- Definition Equipment costs. No definition available.
|
| X | ||||||||||
- Definition Number of capsids. No definition available.
|
| X | ||||||||||
- Definition Option exercise fees payable to related party. No definition available.
|
| X | ||||||||||
- Definition Option exercise fees per selected capsid payable to related party. No definition available.
|
| X | ||||||||||
- Definition Unpaid research and development expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|